Showing results (31-40 of 186) with videos related to
Sort By:
Pageof 19
International Journal of Technology Assessment in Health Care|March 17, 2022
Should We Pay for Scientific Knowledge Spillovers? The Underappreciated Value of "Failed" R&D EffortsRichard Z Xie, Adrian Towse, Louis P GarrisonJournal of Managed Care & Specialty Pharmacy|April 1, 2020
Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment-Rationale and Empirical SupportLouis P Garrison, Bernarda Zamora, Meng Li, et al.Journal of Managed Care & Specialty Pharmacy|February 21, 2019
Value-Based Pricing for Emerging Gene Therapies: The Economic Case for a Higher Cost-Effectiveness ThresholdLouis P Garrison, Tristen Jackson, Douglas Paul, et al.The American Journal of Managed Care|July 24, 2025
Challenges with judging and interpreting a drug's launch priceMelanie D Whittington, Louis P Garrison, Jonathan D CampbellInternational Journal of Technology Assessment in Health Care|November 1, 2022
Toward a broader concept of societal value: family spillovers in Alzheimer's diseaseJenny Yeonhee Park, Zachary A Marcum, Louis P GarrisonJournal of Assisted Reproduction and Genetics|September 25, 2017
Projecting the potential impact of the Cap-Score™ on clinical pregnancy, live births, and medical costs in couples with unexplained infertilityJoseph B Babigumira, Fady I Sharara, Louis P GarrisonCost Effectiveness and Resource Allocation : C/E|March 2, 2021
Reconciling ACEA and MCDA: is there a way forward for measuring cost-effectiveness in the U.S. healthcare setting?Bernarda Zamora, Louis P Garrison, Aig Unuigbe, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 13, 2022
The History and Future of the "ISPOR Value Flower": Addressing Limitations of Conventional Cost-Effectiveness AnalysisPeter J Neumann, Louis P Garrison, Richard J WillkeInternational Journal of General Medicine|December 1, 2022
Value Insider Season 1 Episode 5: What Other Aspects of Value May Be Relevant? (Societal Impact) [Podcast]Louis P Garrison, Elisabeth Sophia Hartgers-Gubbels, Michael ChambersJournal of Managed Care & Specialty Pharmacy|October 31, 2019
Reflections on the ISPOR Special Task Force on U.S. Value Frameworks: Implications of a Health Economics Approach for Managed Care PharmacyLouis P Garrison, Peter J Neumann, Richard J WillkePageof 19